Hospital Acquired Infections: Testing Markets

Aug 14, 2012
117 Pages - Pub ID: KLI4861606
Share this report
 
Online Download $3,995
Departmental Site License (one location, 10 users) $5,750
Global Site License $7,990
A nosocomial, or hospital-acquired, infection is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a hospital-acquired infection (or more generically healthcare-associated infections). The following are among the hospital infections considered in this report:
  • Acinetobacter Baumannii
  • Clostridium Difficile
  • Hospital-Acquired Pneumonia
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Tuberculosis
  • Urinary Tract Infections
  • Vancomycin-resistant Enterococcus
  • Ventilator-Associated Pneumonia
This report focuses on testing for nosocomial infections. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in the hospital setting, and b) the practical aspects of diagnosis and therapy are more meaningful based both on medial considerations and on market considerations. This report Hospital Acquired Infection Testing Markets looks at the market for diagnostics that address the growing nosocomial infection threat. As part of its coverage, the report includes the following information:
  • Market Size Estimate and Growth Forecast for the HAI Diagnostics Market
  • Issues and Trends Affecting Market
  • Common Hospital (nosocomial) Infections
  • Nosocomial Infection Statistics
  • International Hospital Length of Stay Statistics
  • The Role of Molecular Tests vs. Traditional
  • Corporate Profiles of Key Suppliers

Market analysis in this report considers primarily the epidemiological considerations and the sizes patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis. Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the major markets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital environment in order to try and construct a picture of the nosocomial testing and treatment needs.

The primary focus of this report is on the bacterial form of nosocomial infections, and those with significant impact on the hospital setting and markets. In looking at these infections, we consider the diagnostic and therapeutic technologies that are currently available and attempt to project trends for diagnosing these infections. To some extent, we are limited by the activity of the industries associated with the diagnosis and treatment of these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology.

Companies Profiled in the report include the following:
  • Abbott Laboratories
  • Alere
  • Becton, Dickinson
  • bioMerieux
  • Cephei
  • Gen-Probe
  • Meridian Bioscience, Inc.
  • Qiagen GmbH
  • Roche
  • Siemens AG

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, research scientists, business development managers and marketing managers.

CHAPTER ONE: EXECUTIVE SUMMARY
  • Overview
  • Infection Control Summary
  • Scope and Methodology
  • Total Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors
CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
  • Overview
    • Introduction to Pathogens
    • Classification of Antibacterial Organisms
    • Common Hospital (nosocomial) Infections
  • Hospital Units and Infection Risks
    • Burn Units
    • Intensive Care Units
    • Emergency Departments
    • General Infection Statistics
    • Nosocomial Infection Statistics
    • Hospital Length of Stay
    • Populations at Risk for Infection
  • Demographics of the World
    • Life Expectancy
  • Economic Trends
    • Comparison Between Healthcare Spending and Real Health Outcomes
  • Infections and Drug Resistance
    • Causes of Drug Resistance
    • Drug Resistance in Select Populations
    • Measures for Reducing Resistance
    • Screening Hospitalized patients
  • Prevention Measures
    • Potential Use of Copper for Reducing Infection
    • Wide Area Disinfection Methods
    • Software for Infection Detection and Control
  • The American Recovery and Reinvestment Act of 2009
    • U.S. Statewide Standardized Infection Ratio
    • State Level Case Study of HAI Admissions and Readmissions
    • John T. Mather Memorial Hospital/Cepheid-Case Study
  • Manufacturer and Marketer Trends
    • Trends in Partnerships and Alliances
    • Developers Trends
CHAPTER THREE: HOSPITAL INFECTION TESTING PRODUCTS
    Overview
  • Methods of TransmissionTesting Methods
    • Drug-Resistance/Susceptibility Testing
    • Genotypic Methods
  • Specific Nosocomial Disease Testing
    • Acinetobacter Baumannii
    • Clostridium Difficile
    • Hospital-Acquired Pneumonia
    • Pseudomonas Aeruginosa
    • Staphylococcus Aureus
    • Tuberculosis
    • Urinary Tract Infections
    • Vancomycin-resistant Enterococcus
    • Ventilator-Associated Pneumonia
  • New Developments
CHAPTER FOUR: MARKET OPPORTUNITIES FOR HOSPITAL INFECTION TESTING
  • Market Considerations
  • Market Overview
  • Total Market Size and Forecast
    • Hospital Infection Testing Market by Geographical Region
  • Competitive Analysis
CHAPTER FIVE: COMPANY PROFILES
  • Introduction
  • Abbott Laboratories
  • Alere
  • Becton, Dickinson
  • bioMerieux
  • Cephei
  • Gen-Probe
  • Meridian Bioscience, Inc.
  • Qiagen GmbH
  • Roche
  • Siemens AG
APPENDIX: LIST OF MAJOR PROVIDERS


LIST OF EXHIBITS



CHAPTER ONE: EXECUTIVE SUMMARY

  • Table 1-1: Frequency of the Most Common Nosocomial Infections
  • Table 1-2: The World Market for Hospital Infection Testing/Diagnostics 2007-2016
  • Figure 1-1: The World Market for Hospital Infection Testing/Diagnostics 2007-2016
CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
  • Table 2-1: Burn Statistics
  • Figure 2-1: U.S. Hospital Admissions and Percent of Hospital-acquired Infections (HAIs)
  • Table 2-2: U.S. Hospital Length of Stay, Average by Age Group
  • Table 2-3: Average International Length of Stay, by Country 2010
  • Table 2-4: World Population at Risk for Serious Bacterial Infections,Secondary to Chronic Diseases by Selected Geographical Region, 2010
  • Figure 2-2: World Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region, 2010
  • Table 2-5: Estimated World Population by Age and Geographical Region, 2010
  • Figure 2-3: Estimated World Population by Age and Geographical Region, 2010
  • Table 2-6: Average Life Expectancy in Years by Country 1980, 2004 and 2011
  • Figure 2-4: Average Life Expectancy in Years by Country 1980 and 2011
  • Table 2-7: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2010
  • Figure 2-5: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000, and 2010
  • Table 2-8: Healthcare Spending, Obesity and Life Expectancy, 2011
  • Table 2-9: U.S. States Hospital Acquired Infection Standardized Infection Ratio (SIR)
  • Table 2-10: Pennsylvania State Analysis of HAI Readmissions and Related Costs, 2009
  • Table 2-11: Pennsylvania State Analysis of HAIs, 2009
CHAPTER THREE: HOSPITAL INFECTION TESTING PRODUCTS
  • Table 3-1: Recent Approvals for Hospital Infection Testing
  • Table 3-2: New Developments, Hospital Infection Testing, as of July 2012
CHAPTER FOUR: MARKET OPPORTUNITIES FOR HOSPITAL INFECTION TESTING
  • Table 4-1: The World Market for Hospital Infection Testing/Diagnostics 2007-2016
  • Figure 4-1: The World Market for Hospital Infection Testing/Diagnostics 2007-2016
  • Figure 4-2: The World Market for Hospital InfectionTesting/Diagnostics Estimated Market Share by Test Indication, 2011
  • Table 4-2: The World Market for Hospital Infection Testing/Diagnostics Estimated Products Sales by Geographic Region 2007-2016
  • Figure 4-3: The World Market for Hospital Infection Testing/Diagnostics Estimated Product Sales by Geographic Region 2007-2016
  • Figure 4-4: The World Market for Hospital Infection Testing/Diagnostics Estimated Market Share by Region, 2011
  • Table 4-3: The World Market for Hospital Infection Testing/Diagnostics Leading Suppliers’ Shares Estimates for 2011
  • Figure 4-5: The World Market for Hospital Infection Testing/Diagnostics Leading Suppliers’ Shares Estimates for 2011

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.